文献速递新发突发、热带与寄生虫病

螯合现象对非洲恶性疟原虫疟疾中青蒿素诱导的寄生虫清除的影响

The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
PubMed 文献 · Clin Infect Dis · 2023-01-01

该研究分析了2018至2019年乌干达北部133例接受青蒿素单药治疗的恶性疟原虫疟疾患者,从PfHRP2浓度与外周血疟原虫密度估算螯合寄生虫数量。结果显示炎症、血小板减少和血脂异常与螯合独立相关;在Pfkelch13野生型感染中,每微升100万个螯合寄生虫估计使寄生虫清除延迟16.8%(95%CI 5.1%-28.5%),而在A675V突变株中不明显。

要点

  • 在无青蒿素耐药突变的患者中,强烈螯合会延迟青蒿素治疗后的寄生虫清除。
  • 每微升100万个螯合寄生虫估计使野生型感染者的清除延迟16.8%(95%CI 5.1%-28.5%)。
  • 炎症、血小板减少和血脂异常与螯合独立于外周血疟原虫密度相关。

核心结论

  • 在无青蒿素耐药突变的恶性疟原虫疟疾患者中,强烈的螯合会延迟治疗后的寄生虫清除,这可能促使青蒿素疗效降低。

研究设计与样本

  • 该研究分析了2018年和2019年乌干达北部一项青蒿素体内疗效研究纳入的133例恶性疟原虫疟疾患者。
  • 寄生虫清除半衰期根据青蒿素单药治疗后的外周血疟原虫密度估算,并检测治疗前血浆中的PfHRP2,以估算螯合寄生虫数量。

主要发现

  • 估算的每微升血浆螯合寄生虫数量范围为0至2 564 000/μL。
  • 炎症、血小板减少和血脂异常与螯合显著相关,且独立于外周血疟原虫密度。
  • Pfkelch13野生型感染者(n=104)的寄生虫清除半衰期中位数为1.65小时,A675V青蒿素耐药突变感染者(n=18)为3.95小时。
  • 在野生型人群的多变量模型中,每微升100万个螯合寄生虫估计使寄生虫清除延迟16.8%(95%置信区间,5.1%-28.5%),而在A675V人群中尚不清楚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Artemisinin-resistant Plasmodium falciparum is spreading in Southeast Asia and Africa. In vivo susceptibility to artemisinin is studied by looking at the rate of decline of peripheral parasitemia (parasite clearance half-life). However, parasites that are adhered/sequestered to the endothelium and undetectable in the peripheral blood are not considered in the estimation of parasite clearance. Here, we evaluated the influence of sequestration on in vivo artemisinin efficacy in Uganda, where artemisinin resistance is spreading. METHODS: We analyzed 133 patients with P. falciparum malaria included in an in vivo study on artemisinin efficacy in northern Uganda in 2018 and 2019. The parasite clearance half-life was estimated from peripheral parasitemia after artemisinin monotherapy. P. falciparum histidine-rich protein 2 (PfHRP2) was measured in pretreatment plasma. The number of sequestered parasites was estimated from PfHRP2 concentration and peripheral parasitemia. RESULTS: The estimated number of sequestered parasites per plasma volume ranged from 0 to 2 564 000/μL. Inflammation, thrombocytopenia, and dyslipidemia were significantly associated with sequestration independent of peripheral parasitemia. The median parasite clearance half-lives were 1.65 hours in patients infected with Pfkelch13 wild-type parasites (n = 104) and 3.95 hours in those with A675V artemisinin-resistant mutant (n = 18). In the multivariable model for the wild-type population, 1 000 000/μL of sequestered parasites were estimated to delay parasite clearance by 16.8% (95% confidence interval, 5.1%-28.5%), although it was not clear in the A675V population. CONCLUSIONS: In patients with P. falciparum malaria without artemisinin-resistant mutations, intensive sequestration delays parasite clearance after treatment, which may contribute to reduced artemisinin efficacy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Fukuda N, Balikagala B, Ueno T, et al. The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa. Clin Infect Dis. 2023. PMID: 36519341. doi:10.1093/cid/ciac944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。